During the height of the COVID-19 public health emergency, the Office of Sponsored Research (OSR), Office of Clinical Trial Activation (OCTA), and Contracts and Grants Accounting (CGA) remain open for business. We continue to support the research community and have prioritized all COVID-19 research activities.
The potential impact of the respiratory illness COVID-19 continues to evolve. UCSF Office of Sponsored Research (OSR) and Contracts and Grants Accounting (CGA) are actively monitoring the impacts to research activities and funding.
NOT-OD-20-087 provides guidance outlining flexibilities available to recipients conducting NIH-funded clinical trials and human subject studies that are impacted by the declared public health emergency for COVID-19.
At this time, NIH is encouraging recipients to consult with their IRBs about potential measures to protect participants and research staff. For example:
Join Dr. Patricia Brown, Director, NIH Office of Laboratory Animal Welfare (OLAW) and Dr. Brent Morse, Director, Division of Compliance Oversight, OLAW, for this special webinar to learn how to prepare for a pandemic that may impact animal care and use programs.
A one-time enrollment is required: https://olaw.nih.gov/education/online-seminars.htm
Please submit questions in advance to: [email protected].
NOT-OD-20-077 reminds NIH and AHRQ applicants that FORMS-F application packages must be used for due dates on or after May 25, 2020 and FORMS-E application packages for due dates on or before May 24, 2020.
Applicants are encouraged to submit early to work through any unforeseen issues. Applications submitted using the incorrect application package for their due date may be withdrawn and removed from funding consideration.
The notice also provides the following updates: